Patients Challenges and opportunities with plasma-derived therapies This newest pharmaphorum podcast welcomes Takeda's Dr Kristina Allikmets.
R&D Open science: disrupting scientific community collaboration The quiet rise of collaboration among pharma companies has never been more important.
R&D Making a difference for traumatic brain injury patients TBI is the leading cause of death and disability in young adults in the developed world.
R&D Allogeneic therapies: The future of cancer treatment? Allogeneic therapies could provide an answer to some of the drawbacks of autologous therapies.
R&D 12 Questions with Ben Wiegand 12 Question with Ben Wiegand: transforming healthcare from disease care to health care.
R&D IWD: Aline Gégout on women in STEM To mark International Women’s Day 2023, we caught up with Aline Gégout of Roche Diabetes Care.
News Rezzayo antifungal okayed as Candida auris rings alarm bells Drug is first new echinocandin to be approved for marketing in the US in more than a decade.
R&D Sponsored An inside guide to unlocking clinical research in the UK An inside guide to unlocking clinical research in the UK
